FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378806106> ?p ?o ?g. }

• W4378806106 endingPage "949" @default.
• W4378806106 startingPage "942" @default.
• W4378806106 abstract "Extracorporeal membrane oxygenation (ECMO) is increasingly used in COVID-19-related pulmonary failure and the number of patients recovering from COVID-19 is growing. Here, we assess survival and recovery 6 months after ECMO for COVID-19. From April 2020 to September 2021, n = 60 (60.5 [51.0-65.0] years, 23.3% female) were treated with venovenous/venoarterial ECMO for COVID-19. 41.7% were weaned off ECMO, survival-to-discharge was 40.0% (n = 24). Age (63.0 [60.0-66.8] vs. 55.0 [43.8-60.0] years, p < 0.001), vasoactive support (97.2% vs . 75.0%, p = 0.013), and pre-ECMO SOFA scores (13.0 [12.0-14.8] vs. 12.0 [10.0-13.8] p = 0.036) correlated with nonsurvival. All patients aged >65 years, with histories of neoplasia, immunocompromise, chronic renal failure, or frailty died. After 6 months, 20 were alive (6-month survival 33.3%, survival conditioned on survival-to-discharge 83.3%), with follow-up in 19. 57.9% showed no relevant, 26.3% moderate, 15.8% severe deficits. Cardiopulmonary status was satisfactory (mMRC level: 84.2% ≤2). 73.7% were independent in daily life. Cognitive impairments were frequent (52.6%). 26.3% showed moderate depression, 15.8% posttraumatic stress disorder. Social and work life were considerably affected. Extracorporeal membrane oxygenation thus can serve as salvage therapy in COVID-19, but advanced age, immunocompromise, histories of neoplasia, and frailty must be considered as relative contraindications. Age, vasoactive support, and SOFA scores assist discriminating in daily practice. Deficits after 6 months are substantial, and efforts need to focus on long-term recovery." @default.
• W4378806106 created "2023-06-01" @default.
• W4378806106 creator A5000891922 @default.
• W4378806106 creator A5005978365 @default.
• W4378806106 creator A5009981277 @default.
• W4378806106 creator A5015237090 @default.
• W4378806106 creator A5023704909 @default.
• W4378806106 creator A5027905822 @default.
• W4378806106 creator A5033599657 @default.
• W4378806106 creator A5044637652 @default.
• W4378806106 creator A5072581877 @default.
• W4378806106 creator A5077802539 @default.
• W4378806106 creator A5080143151 @default.
• W4378806106 creator A5080895294 @default.
• W4378806106 creator A5083255874 @default.
• W4378806106 creator A5084686460 @default.
• W4378806106 creator A5090485977 @default.
• W4378806106 date "2023-05-31" @default.
• W4378806106 modified "2023-10-12" @default.
• W4378806106 title "Functional Status and Quality of Life 6 Months After Extracorporeal Membrane Oxygenation Therapy for COVID-19-Related Pulmonary Failure" @default.
• W4378806106 cites W1988226846 @default.
• W4378806106 cites W1996204666 @default.
• W4378806106 cites W2020074777 @default.
• W4378806106 cites W2165852759 @default.
• W4378806106 cites W2303506282 @default.
• W4378806106 cites W2800274554 @default.
• W4378806106 cites W2809193487 @default.
• W4378806106 cites W3009885589 @default.
• W4378806106 cites W3013643089 @default.
• W4378806106 cites W3038199445 @default.
• W4378806106 cites W3048382678 @default.
• W4378806106 cites W3089328061 @default.
• W4378806106 cites W3113235424 @default.
• W4378806106 cites W3120387768 @default.
• W4378806106 cites W3124281496 @default.
• W4378806106 cites W3127129273 @default.
• W4378806106 cites W3134724323 @default.
• W4378806106 cites W3138791341 @default.
• W4378806106 cites W3160191138 @default.
• W4378806106 cites W3162112709 @default.
• W4378806106 cites W3199803879 @default.
• W4378806106 cites W3202915227 @default.
• W4378806106 cites W3204570230 @default.
• W4378806106 cites W3208119506 @default.
• W4378806106 cites W3212364097 @default.
• W4378806106 cites W3214978197 @default.
• W4378806106 cites W3215361933 @default.
• W4378806106 cites W3215754745 @default.
• W4378806106 cites W3216352771 @default.
• W4378806106 cites W4210718324 @default.
• W4378806106 cites W4210927252 @default.
• W4378806106 cites W4213308794 @default.
• W4378806106 cites W4226497332 @default.
• W4378806106 cites W4283769245 @default.
• W4378806106 doi "https://doi.org/10.1097/mat.0000000000001993" @default.
• W4378806106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37256794" @default.
• W4378806106 hasPublicationYear "2023" @default.
• W4378806106 type Work @default.
• W4378806106 citedByCount "1" @default.
• W4378806106 crossrefType "journal-article" @default.
• W4378806106 hasAuthorship W4378806106A5000891922 @default.
• W4378806106 hasAuthorship W4378806106A5005978365 @default.
• W4378806106 hasAuthorship W4378806106A5009981277 @default.
• W4378806106 hasAuthorship W4378806106A5015237090 @default.
• W4378806106 hasAuthorship W4378806106A5023704909 @default.
• W4378806106 hasAuthorship W4378806106A5027905822 @default.
• W4378806106 hasAuthorship W4378806106A5033599657 @default.
• W4378806106 hasAuthorship W4378806106A5044637652 @default.
• W4378806106 hasAuthorship W4378806106A5072581877 @default.
• W4378806106 hasAuthorship W4378806106A5077802539 @default.
• W4378806106 hasAuthorship W4378806106A5080143151 @default.
• W4378806106 hasAuthorship W4378806106A5080895294 @default.
• W4378806106 hasAuthorship W4378806106A5083255874 @default.
• W4378806106 hasAuthorship W4378806106A5084686460 @default.
• W4378806106 hasAuthorship W4378806106A5090485977 @default.
• W4378806106 hasConcept C116675565 @default.
• W4378806106 hasConcept C126322002 @default.
• W4378806106 hasConcept C142724271 @default.
• W4378806106 hasConcept C159110408 @default.
• W4378806106 hasConcept C164705383 @default.
• W4378806106 hasConcept C177713679 @default.
• W4378806106 hasConcept C2776858399 @default.
• W4378806106 hasConcept C2776888751 @default.
• W4378806106 hasConcept C2779134260 @default.
• W4378806106 hasConcept C2779541074 @default.
• W4378806106 hasConcept C2779915274 @default.
• W4378806106 hasConcept C2779951463 @default.
• W4378806106 hasConcept C2780409771 @default.
• W4378806106 hasConcept C3006700255 @default.
• W4378806106 hasConcept C3007834351 @default.
• W4378806106 hasConcept C3008058167 @default.
• W4378806106 hasConcept C42219234 @default.
• W4378806106 hasConcept C524204448 @default.
• W4378806106 hasConcept C71924100 @default.
• W4378806106 hasConceptScore W4378806106C116675565 @default.
• W4378806106 hasConceptScore W4378806106C126322002 @default.
• W4378806106 hasConceptScore W4378806106C142724271 @default.
• W4378806106 hasConceptScore W4378806106C159110408 @default.

• next